1. [The effect of pharmacological preparations on the regulation of growth hormone secretion].
- Author
-
Bershteĭn LM, Gamaiunova VB, Poroshina TE, Simonov NN, Guliaev AV, Leonchuk AD, and Dil'man VM
- Subjects
- Breast Neoplasms blood, Breast Neoplasms drug therapy, Breast Neoplasms metabolism, Drug Therapy, Combination, Endometrial Neoplasms blood, Endometrial Neoplasms drug therapy, Endometrial Neoplasms metabolism, Female, Fibroadenoma blood, Fibroadenoma drug therapy, Fibroadenoma metabolism, Glucose Tolerance Test, Growth Hormone blood, Humans, Insulin blood, Intestinal Neoplasms blood, Intestinal Neoplasms drug therapy, Intestinal Neoplasms metabolism, Intestine, Large, Middle Aged, Time Factors, Growth Hormone drug effects, Growth Hormone metabolism
- Abstract
The authors have assessed the effects of 7 metabolic and 5 neutral drugs and their combinations on the basal blood concentration of the growth hormone (GH) and on the sensitivity of GH-regulating centers to homeostatic glucose inhibition. No significant changes in GH basal level were revealed. Nacom and a combination of vitamins E and C reduced the threshold sensitivity to glucose inhibition of the GH, whereas miscleron and trental elevated this threshold sensitivity. A combination of butamid and nacom had the highest stimulatory effect on the cellular immunity and macrophagal function, that may be mediated by enhanced GH secretion. In subjects with the 'superior' (android) type of obesity GH basal concentration and its sensitivity to glucose inhibition were lower than in those with the 'inferior' (gynoid) type, this being true after the drug discontinuation.
- Published
- 1993